Corcept Therapeutics (CORT) Inventory Average (2012 - 2026)

Corcept Therapeutics has disclosed Inventory Average across 15 years of filings, most recently posting $12.9 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $12.9 million, down 3.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (down 3.82% YoY), and the FY2025 annual result was $12.6 million, up 25.51% from the prior year.
• Inventory Average came in at $12.9 million for Q1 2026 at Corcept Therapeutics, up from $12.6 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $13.4 million in Q1 2025 to a low of $5.0 million in Q1 2022.
• The 5-year median for Inventory Average is $7.6 million (2023), against an average of $8.7 million.
• Across the five-year window, Inventory Average soared 79.49% in 2025 and decreased 3.82% in 2026, its largest moves.
• Corcept Therapeutics' Inventory Average stood at $6.1 million in 2022, then advanced by 25.5% to $7.6 million in 2023, then soared by 34.24% to $10.2 million in 2024, then rose by 23.24% to $12.6 million in 2025, then rose by 2.15% to $12.9 million in 2026.
• The last three Inventory Average figures came in at $12.9 million (Q1 2026), $12.6 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.